A carregar...
Is a Short-course of Preoperative Denosumab as Effective as Prolonged Therapy for Giant Cell Tumor of Bone?
BACKGROUND: Denosumab is an inhibitor of monoclonal receptor activator of nuclear factor-ĸB ligand, approved to treat giant cell tumors of bone (GCTB). It is commonly used for unresectable tumors and for downstaging the tumor to perform less-morbid procedures. Although denosumab has been used extens...
Na minha lista:
| Publicado no: | Clin Orthop Relat Res |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7594929/ https://ncbi.nlm.nih.gov/pubmed/32401001 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CORR.0000000000001285 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|